首页> 外文期刊>Advances in Animal and Veterinary Sciences >Pharmacokinetics of Tetracycline and Tetracycline Loaded Nanoemulsion Formula in Rabbits
【24h】

Pharmacokinetics of Tetracycline and Tetracycline Loaded Nanoemulsion Formula in Rabbits

机译:兔四环素和四环素负载纳米乳液配方的药代动力学

获取原文
           

摘要

Nano-sized drug delivery systems?used?to?improve?drug pharmacokinetics especially bioavailability.?Different tetracycline loaded?nanoemulsions?were formulated?and evaluated for thermodynamic stability, morphology, droplet size and zeta potential measurements.?Pharmacokinetic?of TC-NE?(10%?Mig, 50% S/CoS and 40% water with drug concentration of?5%, w/w) was investigated in rabbits following a single oral and IV doses (50 mg/kg?bwt) and compared to tetracycline?HCl?powder (TC-?Powder) at the same dose.?Tetracycline concentrations were determined in plasma samples using standard high performance liquid chromatography?(HPLC)?procedure. Following IV injection higher AUC0-inf (83.3 ± 4.2 and 74.8 ± 2.9 μg/ml.h) and volume of distribution?(Vdss)?(0.78 ± 0.06?L/kg and?0.71 ± 0.10?L/kg) reported?for TC-NE compared to TC-Powder, respectively.?Furthermore, after oral administration,?TC-NE was slowly absorbed and eliminated than TC-Powder with longer t1/2ka?(0.518 ± 0.091 h and?0.253 ± 0.024?h) and t1/2β?(4.22 ± 1.67 h and 3.33 ± 0.68 h), respectively. Moreover, the time at which?maximum?tetracycline plasma concentration achieved (Tmax) was 0.869 ± 0.059 h for TC--NE and 0.397 ± 0.033 h for TC-Powder. Significantly higher area under curve AUC0-t 20.4 ± 1.5?μg/ml.h and 11.1 ± 0.6 μg/ml.h and?consequently?higher bioavailability 29.2 ± 2.3% and 13.9 ± 0.8% was recorded for TC-NE than TC-Powder, respectively. Following oral admistiration TC-NE formula exhibited prolonged T MIC of 10.36 ± 0.64 h compared to 7.1±0.32 h in TC-powder. In conclusion, the?prepared?Tetracycline loaded?nanoemulsion formulation has improved oral bioavailability and prolonged the blood concentration time than TC-Powder. Further clinical studies?are required?to?justify?dosage that supports clinical efficiency.
机译:纳米尺寸的药物递送系统?使用?到?药物药代动力学尤其是生物利用性。加载αδ纳米乳剂?并评估热力学稳定性,形态,液滴尺寸和Zeta电位测量。TC-Ne ?(10%?MIG,50%S / COS和40%的水浓度,在单个口腔和IV剂量(50mg / kgβbWT)后,在兔子中研究了β5%,w / w)的兔子·5%w / w)。与四环素?HCl?粉末(Tc-α粉末)在相同剂量的同一剂量。使用标准高效液相色谱法在等离子体样品中测定同等的旋赤素浓度?(HPLC)?程序。 IV注射术后高于AUC0-INF(83.3±4.2和74.8±2.9μg/ ml.H)和分布体积?(VDSS)?(0.78±0.06?L / kg和?0.71±0.10?l / kg)报告?对于TC-Ne,分别与TC-粉末相比。在口服施用后,αΔTC-NE缓慢吸收和消除,比TC-粉末更长的T1 / 2KA?(0.518±0.091h,α0.253±0.024?h )和T1 /2β(4.22±1.67 h和3.33±0.68小时)。此外,TC - Ne的达到(Tmax)达到(Tmax)的最大β(Tmax)的时间(Tmax)为0.869±0.033小时。在曲线Auc0-t的明显高度较高的区域20.4±1.5?μg/ ml.h和11.1±0.6μg/ ml.h和?因此较高的生物利用度29.2±2.3%和13.9±0.8%,对于TC-NE而不是TC-粉末分别。在口服前进的TC-NE配方之后,延长的T> MIC为10.36±0.64h,而TC-粉末中的7.1±0.32小时。总之,制备的α·四环素负载?纳米乳剂配方具有改善的口服生物利用度,延长血液浓度的时间而不是Tc-粉末。进一步的临床研究?是必需的吗?对齐?为支持临床效率的剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号